| Literature DB >> 34823476 |
Liting Wu1, Hongduo Bao1, Zhengquan Yang2, Tao He1, Yuan Tian1,3, Yan Zhou1, Maoda Pang1, Ran Wang1, Hui Zhang4.
Abstract
BACKGROUND: Listeria monocytogenes is one of the deadliest foodborne pathogens. The bacterium can tolerate severe environments through biofilm formation and antimicrobial resistance. This study aimed to investigate the antimicrobial susceptibility, resistance genes, virulence, and molecular epidemiology about Listeria from meat processing environments.Entities:
Keywords: Antimicrobial resistance; Antimicrobial resistance genes; Listeria; MLST; Virulence
Mesh:
Substances:
Year: 2021 PMID: 34823476 PMCID: PMC8613961 DOI: 10.1186/s12866-021-02335-7
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Isolation frequency of Listeria from pig slaughter factory
| Sample type | No. of samples | No. of | No. of positive samples (%) |
|---|---|---|---|
| Slaughter area (A) | 80 | 7 (8.75) | |
| Cutting and deboning room (B) | 80 | 9 (11.25) | |
| Visceral area (C) | 80 | 23 (28.75) | |
| Meat cooling and refrigeration area (D) | 80 | 20 (25.00) | |
| Total | 320 | 59 (18.44) |
Phylogenetic groups of tested L. isteria strains (n = 59)
Serotypes and isolation regions of L. monocytogenes isolates
| Group | Number of | Total | |||
|---|---|---|---|---|---|
| Slaughter area (A) | Cutting and deboning room (B) | Visceral area (C) | Meat cooling and refrigeration area (D) | ||
| 1/2a | ND | ND | LM3–11 | LM1, LM2, LM3, LM6, LM7, LM8, | 7 (18.91%) |
| 1/2b | LMA1, LMA8, LMA9, LMA13, LMA-II | LMB4, LMB-I | LMC4, LMC9, LMC15, LMC-I | LMD3, LMD10 | 13 (35.14%) |
| 1/2c | ND | LM2–18 | LM3–2-2,LM3–19, LM3–20-2 | LM1T7, LM2T3, LM2W3 | 7 (18.92%) |
| 3a | LM1–9 | ND | LMC11 | LM4 | 3 (8.11%) |
| 3c | ND | ND | LMX-3, LMC7 | LM1W3 | 3 (8.11%) |
| 3b | ND | LMB5, LMB9, LMB10, LMB13 | ND | ND | 4 (10.81%) |
| Total | 6 | 7 | 11 | 13 | 37 (100%) |
ND represents “None determined
Antimicrobial-resistance profiles of Listeria isolates from the four areas (n = 59)
| Source and no. of resistant strains (%) | ||||||
|---|---|---|---|---|---|---|
| Antibitocs | Slaughter area | Cutting and deboning room | Visceral area | Meat cooling and refrigeration area | Total | |
| GEN | R ≥ 16 | 0 (0.00%) | 0 (0.00%) | 2 (3.39%) | ||
| I = 8 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (1.69%) | ||
| S ≤ 4 | 56 (94.92%) | |||||
| CAZ | R ≥ 32 | 58 (98.31%) | ||||
| I = 16 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| S ≤ 8 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (1.70%) | ||
| AMP | R ≥ 32 | (14.29%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (1.69%) |
| I = 16 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| S ≤ 8 | 58 (98.31%) | |||||
| CIP | R ≥ 4 | 57 (96.61%) | ||||
| I = 2 | 0 (0.00%) | 0 (0.0%) | 0 (0.0%) | 1 (1.69%) | ||
| S ≤ 1 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (1.69%) | ||
| TET | R ≥ 16 | 10 (16.95%) | ||||
| I = 8 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| S ≤ 4 | 49 (83.05%) | |||||
| ERY | R ≥ 8 | 0 (0.00%) | 0 (0.00%) | 4 (6.78%) | ||
| I = 1–4 | (50.00%) | 29 (49.15%) | ||||
| S ≤ 0.5 | 26 (44.07%) | |||||
| LIN | R ≥ 4 | (85.71%) | 55 (93.22%) | |||
| I = 1–2 | 0 (0.00%) | 4 (6.78%) | ||||
| S - | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| VAN | R ≥ 32 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| I = 8–16 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| S ≤ 4 | 59 (100.00%) | |||||
GEN gentamicin, CAZ ceftazidime, AMP ampicillin, CIP ciprofloxacin, TET tetracycline, ERY erythromycin, LIN lincomycin, VAN vancomycin
Fig. 1Resistant analysis of L. welshimeri, L. inocua and L. monocytogenes. Gentamicin (GEN), ampicillin (AMP), ceftazidime (CAZ), ciprofloxacin (CIP), tetracycline (TET), erythromycin (ERY), lincomycin (LIN) and vancomycin (VAN) were selected as test antibiotics. Streptococcus pneumonia ATCC 49619 was selected as the quality control strain
Fig. 2Antimicrobial susceptibility of L. monocytogenes isolates from processing plants to eight antibiotics. Gentamicin (GEN), ampicillin (AMP), ceftazidime (CAZ), ciprofloxacin (CIP), tetracycline (TET), erythromycin (ERY), lincomycin (LIN) and vancomycin (VAN) were selected as test antibiotics. A:non-resistance, B:one-resistance, C:two-resistance, D:three-resistance, E:four-resistance, F: five-resistance, G:six-resistance, H:seven-resistance, I:eight-resistance. Streptococcus pneumonia ATCC 49619 was selected as the quality control strain
Fig. 4Serotypes, resistance, source, and STs of the Listeria isolates from the processing environment. MLST performed based on seven housekeeping genes (abcZ, bglA, cat, dapE, dat, ldh and lhkA) according to the previous method. Genotypic data are available at http://bigsdb.web.pasteur.fr/listeria/. Minimum spanning tree analysis was inferred using BioNumerics (Version 5.10, Applied Maths, Belgium). ND represents: None determined
Correlation rate of phenotype and genotype of the Listeria spp
| Antibiotics | Resistant strains | Resistance genes | Resistance genes strains |
|---|---|---|---|
| Tetracycline | 9 | 36 | |
| 24 | |||
| 0 | |||
| Ciprofloxacin | 57 | 4 | |
| Eryphilin | 4 | 10 | |
| 8 | |||
| 9 | |||
| Ceftazidime | 58 | 0 | |
| Vancomycin | 0 | 0 | |
| 0 |
Fig. 3Resistance genotypes of 59 Listeria isolates. Eleven resistance genes tetA, tetM, tetS, ermA, ermB, ermC, aac(6′)-Ib, mecA, vanA, vanB, and cfr were selected as specific resistance genes and were identified by PCR within Listeria spp. . Primers used in this study are listed in Table 5
Primer used in this study for amplification of resistance genes of the Listeria spp
| Category | Gene | Primer | Size | Accession number | Reference |
|---|---|---|---|---|---|
| Tetracycline | F:GCTACATCCTGCTTGCCTTC | 220 | NG_048154.1 | [ | |
| R:CATAGATCGCCGTGAAGAGG | |||||
| F:GTGGACAAAGGTACAACGAG | 974 | NC_013929.1 | |||
| R:CGGTAAAGTTCGTCACACAC | |||||
| F:CATAGACAAGCCGTTGACC | 1050 | NC_013929.1 | |||
| R:ATGTTTTTGGAACGCCAGAG | |||||
| Aminoglycosides | F:TTGCGATGCTCTATGAGTGGCTA | 544 | NZ_CP016990.1 | [ | |
| R:CTCGAATGCCTGGCGTGTTT | |||||
| Macrolides | F:AAGCGGTAAAACCCCTCGAG | 651 | MH_830363.1 | ||
| R:TCA AAGCCTGTCGGATTGG | |||||
| F:GAAAAGGTACTCAACCAAATA | 639 | NG_047798.1 | |||
| R:CATTTGTTAAATTCATGGCAATGA | |||||
F:TCAAAACATAATATAGATAAA R:GCTAATATTGTTTAAATCGTCAAT | 641 | NG_047806.1 | |||
| ESBLs | F:TAGAAATGACTGAACGTCCG | 154 | NG_047937 | [ | |
| R:TTGCGATCAATGTTACCGTAG | |||||
| Vancomycin | F:GGGAAA ACGACAATTGC | 732 | NC_011916.1 | [ | |
| R:GTACAA TGCGGCCGTTA | |||||
| F:TTGATGTGGCTTTCCCGGTT | 544 | NC_011916.1 | |||
| R:ACCCGATTTCGTTCCTCGAC | |||||
Multi-drugefflux pump gene | F:CGATTTGAGGATATGAAGGTTCT | 416 | NG_047631.1 | [ | |
| R:AAATTAGGATCCGTAAACGAAT |
Fig. 5Invasion level of L. monocytogenes isolates against the human colorectal adenocarcinoma cell line Caco-2 cells. In vitro invasion was performed in the Caco-2 cell line (3.0 × 105 cells per well) infected with 1.0 × 107 - 2.0 × 107 L. monocytogenes cells/well. After contact for 90 min, viable intracellular bacteria were enumerated by plating appropriate dilutions of the cell lysate on BHI agar. Error bars represent standard deviations of the mean. ATCC19114 strain was included as an invasion control. Significant difference compared with ATCC19114; *** P < 0.01; ** P < 0.05; *P > 0.05
Primer used in this study for amplification of virulence genes of L. monocytogenes
| Gene | Primer | Size(bp) | Accession number | Reference |
|---|---|---|---|---|
| F:AGCGAGAACGGGACCATC | 285 | EU372057.1 | [ | |
| R:TTGACCGCAAATAGAGCC | ||||
| F:CCCAGAACTGACACGAGC | 293 | |||
| R:GCAGCATACTGACGAGG | ||||
| F:AGACGCTATTGATGCCGATGA | 91 | |||
| R:GTATTGCGCGTTGTCTTCGA | ||||
| F:ATTAACCAAACCACTGGCTCA | 502 | [ | ||
| R:TTGATAAGCAGTCTGGACAAT | ||||
| F:ATAAGTGATATAAGCCCAG | 606 | |||
| R:TTTATCCGTACTGAAATTCC | ||||
| F:GTTGCAAGCGCTTGGAGTGAA | 420 | |||
| R:ACGTATCCTCCAGAGTGATGG | ||||
| F:CCAAAAGTATCTCAACCTGAT | 642 | |||
| R:CATGCATTTGTGATATATCGA |